Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?

European Journal of Health Economics

Volumn 16, Issue 8, 2015, Pages 847-855

  Pullenayegum, Eleanor M ^a   Perampaladas, Kuhan ^b   Gaebel, Kathryn ^b   Doble, Brett ^c   Xie, Feng ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MONASH UNIVERSITY   (Australia)

Author keywords

EQ 5D; Health utility; Heterogeneity; Scoring algorithm

Indexed keywords

ALGORITHM; ARTICLE; CANADA; CORRELATION COEFFICIENT; FRANCE; FREQUENCY; HEALTH STATUS; HUMAN; INDEPENDENT VARIABLE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SOUTH KOREAN; SYSTEMATIC REVIEW (TOPIC); TAIWANESE; UNITED STATES; ATTITUDE TO HEALTH; COMPARATIVE STUDY; INTERNATIONAL COOPERATION; QUESTIONNAIRE;

ALGORITHMS; ATTITUDE TO HEALTH; HEALTH STATUS; HUMANS; INTERNATIONALITY; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES;

EID: 84944177251     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-014-0633-1     Document Type: Article

References (28)

1. National Institute for Health and Care Excellence: Guide to the methods of technology appraisal. National Institute for Health and Care Excellence, London, UK. http://publications.nice.org.uk/pmg9 (2013)
2. Canadian Agency for Drugs and Technology in Health: Guidelines for economic evaluation of health technologies, 3rd edn. Canadian Agency for Drugs and Technology in Health, Ottawa, ON, Canada (2006)
3. EuroQol–a new facility for the measurement of health-related quality of life.: The EuroQol group. Health Policy. 16, 199–208 (1990)
4. Dolan, P.: Modeling valuations for EuroQol health states. Med. Care 35, 1095–1108 (1997)
5. Badia, X., Roset, M., Herdman, M., Kind, P.: A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med. Decis. Making 21, 7–16 (2001)
6. Johnson, J.A., Luo, N., Shaw, J.W., Kind, P., Coons, S.J.: Valuations of EQ-5D health states: are the United States and United Kingdom different? Med. Care 43, 221–228 (2005)
7. Tsuchiya, A., Ikeda, S., Ikegami, N., et al.: Estimating an EQ-5D population value set: the case of Japan. Health Econ. 11, 341–353 (2002)
8. Shaw, J.W., Johnson, J.A., Chen, S., Levin, J.R., Coons, S.J.: Racial/ethnic differences in preferences for the EQ-5D health states: results from the USA valuation study. J. Clin. Epidemiol. 60, 479–490 (2007)
9. Shaw, J.W., Johnson, J.A., Coons, S.J.: USA valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med. Care 43, 203–220 (2005)
10. Jo, M.W., Yun, S.C., Lee, S.I.: Estimating quality weights for EQ-5D health states with the time trade-off method in South Korea. Value Health 11, 1186–1189 (2008)
11. Zarate, V., Kind, P., Valenzuela, P., Vignau, A., Olivares-Tirado, P., Munoz, A.: Social valuation of EQ-5D health states: the Chilean case. Value Health 14, 1135–1141 (2011)
12. Macaran S, Kind P.: Valuing EQ-5D health states using a modified MVH protocol. Prelim. Results 16, 205–39 (1999)
13. Lamers, L.M., McDonnell, J., Stalmeier, P.F., Krabbe, P.F., Busschbach, J.J.: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 15, 1121–1132 (2006)
14. Chuang, L.H., Kind, P.: The effect of health state selection on the valuation of EQ-5D. Med. Decis. Making 31, 186–194 (2011)
15. Viney, R., Norman, R., King, M.T., et al.: Time trade-off derived EQ-5D weights for Australia. Value Health 14, 928–936 (2011)
16. Wittrup-Jensen, K.U., Lauridsen, J., Gudex, C., Pedersen, K.M.: Generation of a Danish TTO value set for EQ-5D health states. Scand. J. Public Health 37, 459–466 (2009)
17. Bansback, N., Tsuchiya, A., Brazier, J., Anis, A.: Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies. PLoS One 7, e31115 (2012)
18. Golicki, D., Jakubczyk, M., Niewada, M., Wrona, W., Busschbach, J.J.: Valuation of EQ-5D health states in poland: first TTO-based social value set in central and eastern Europe. Value Health 13, 289–297 (2010)
19. Norman, R., Cronin, P., Viney, R., King, M., Street, D., Ratcliffe, J.: International comparisons in valuing EQ-5D health states: a review and analysis. Value Health 12, 1194–1200 (2009)
20. Xie F, Gaebel K, Perampaladas K, Doble B, Pullenayegum EM.: Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist. Med. Decis. Making 22 Mar 2013 (epub ahead of print)
21. Augustovski, F.A., Irazola, V.E., Velazquez, A.P., Gibbons, L., Craig, B.M.: Argentine valuation of the EQ-5D health states. Value Health 12, 587–596 (2009)
22. Chevalier J, de Pouvourville G.: Valuing EQ-5D using time trade-off in France. Eur. J. Health. Econ. (2011)
23. Greiner, W., Claes, C., Busschbach, J.J., von der Schulenburg, J.M.: Validating the EQ-5D with time trade-off for the German population. Eur. J. Health. Econ. 6, 124–130 (2005)
24. Jelsma, J., Hansen, K., De Weerdt, W., De Cock, P., Kind, P.: How do Zimbabweans value health states? Popul. Health Metr. 1, 11 (2003)
25. Kind, P.: Valuing health benefits using the EQ-5D: the West Lothian question. In: Stavem, K. (ed.) 22nd Plenary meeting of the EuroQol Group, Oslo, Norway, pp. 55–77 (2005)
26. Shaw, J.W., Pickard, A.S., Yu, S., et al.: A median model for predicting United States population-based EQ-5D health state preferences. Value Health 13, 278–288 (2010)
27. Zarate, V., Kind, P., Chuang, L.H.: Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans. Value Health 11, 1170–1177 (2008)
28. Chang, T.J., Tarn, Y.H., Hsieh, C.L., Liou, W.S., Shaw, J.W., Chiou, X.G.: Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population. J. Formos. Med. Assoc. 106, 1023–1031 (2007)